INFECTIVITY OF HSIV-VIF CHIMERA IN PIGTAILED MACAQUES

HSIV-VIF 嵌合体在斑尾猕猴中的感染性

• 批准号: 8357599
• 负责人: Shiu-Lok Hu
• 金额: $ 37.79万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8357599
• 关键词: Animal Model; Animals; Blood Cells; Chimera organism; Disease; Engineering; Family suidae; Funding; Grant; HIV-1; Human; Infection; Integration Host Factors; Macaca; Macaca mulatta; Macaca nemestrina; Mediating; Medicine; National Center for Research Resources; Pilot Projects; Plasma; Primates; Principal Investigator; Protein Isoforms; Proteins; Research; Research Infrastructure; Resistance; Resources; SIV; Source; Tail; Testing; United States National Institutes of Health; Viral; Viral Load result; Viremia; Virion; Virus; college; cost; improved; in vivo; insight; particle; prevent; vif Genes

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Currently, there is no animal model for HIV-1 infection and disease because the virus is highly specific for humans. Macaques are generally resistant to HIV-1, with the exception being pig-tailed macaques. Our lab showed that pig-tailed macaques are unable to express functional isoforms of TRIM5-alpha, which has been identified as a host factor that restricts the replication of HIV-1 in rhesus monkeys. Therefore, it is possible that HIV-1 will only need to overcome restriction by another host factor, APOBEC3G/F, to replicate successfully in pig-tailed macaques. To test this hypothesis, we collaborated with Dr. J. Kimata of Baylor College of Medicine, who engineered an HIV-1 clone that includes the vif gene of SIVmne, allowing it to counteract APOBEC3G/F-mediated restriction. This chimeric virus, Pt-tropic HIV-1, is 96% HIV-1 and 4% SIV. It replicates in stimulated pig-tailed macaque blood cells as efficiently as SIVmne. In this pilot study, we inoculated 2 pig-tailed macaques intravenously with HSIV-vif. Both animals became infected and seroconverted, with plasma viremia detectable 1 wk after infection and reaching a peak between 104-105 copies/ml at wk 2.. Plasma viral load persisted for 10 months after infection between 102-103 copies/ml, but remained at baseline (d102 copies/ml) thereafter. To gain further insight on factors required for robust infection in pig-tailed macaques, we identified two notable differences between the Pt-tropic HIV-1 and SIVmne (1) SIV Vif does not associate with Pt-tropic HIV-1 viral particles; (2) while Pt-tropic HIV-1 degrades both Pt APOBEC3G and APOBEC3F, it prevents their inclusion in virions to a lesser extent than pathogenic SIVmne. Thus, while SIV Vif is necessary for persistent infection by Pt-tropic HIV-1, improved expression and inhibition of APOBEC3 proteins may be required for robust viral replication in vivo.

这个子项目是利用这些资源的众多研究子项目之一